These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18003188)

  • 1. Spectral clustering of fMRI data within regions of interest: clarification of L-dopa effects in Parkinson's disease.
    Lee PW; Wang Z; Palmer SJ; McKeown MJ
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():5235-8. PubMed ID: 18003188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focusing effects of L-dopa in Parkinson's disease.
    Ng B; Palmer S; Abugharbieh R; McKeown MJ
    Hum Brain Mapp; 2010 Jan; 31(1):88-97. PubMed ID: 19585587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
    Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
    Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A framework for group analysis of fMRI data using dynamic Bayesian networks.
    Li J; Wang ZJ; McKeown MJ
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():5992-5. PubMed ID: 18003379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint spatial denoising and active region of interest delineation in functional magnetic resonance imaging.
    Ng B; Abugharbieh R; Palmer SJ; McKeown MJ
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3404-7. PubMed ID: 18002728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing the connectivity between regions of interest: an approach based on cluster Granger causality for fMRI data analysis.
    Sato JR; Fujita A; Cardoso EF; Thomaz CE; Brammer MJ; Amaro E
    Neuroimage; 2010 Oct; 52(4):1444-55. PubMed ID: 20472076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic Bayesian network modeling of fMRI: a comparison of group-analysis methods.
    Li J; Wang ZJ; Palmer SJ; McKeown MJ
    Neuroimage; 2008 Jun; 41(2):398-407. PubMed ID: 18406629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries.
    Lewis MM; Slagle CG; Smith AB; Truong Y; Bai P; McKeown MJ; Mailman RB; Belger A; Huang X
    Neuroscience; 2007 Jun; 147(1):224-35. PubMed ID: 17499933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for predicting the outcomes of combined pharmacologic and deep brain stimulation therapy for Parkinson's disease.
    Shamir RR; Dolbert T; Noecker AM; Frankemolle AM; Walter BL; McIntyre CC
    Med Image Comput Comput Assist Interv; 2014; 17(Pt 2):188-95. PubMed ID: 25485378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of fMRI-derived ROIs based on coherent functional interaction patterns.
    Deng F; Zhu D; Liu T
    Med Image Comput Comput Assist Interv; 2012; 15(Pt 3):214-22. PubMed ID: 23286133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving influx constant and ratio estimation in FDOPA brain PET analysis for Parkinson's disease.
    Pan XB; Wright TG; Leong FJ; McLaughlin RA; Declerck JM; Silverman DH
    J Nucl Med; 2005 Oct; 46(10):1737-44. PubMed ID: 16204725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of fMRI data using improved self-organizing mapping and spatio-temporal metric hierarchical clustering.
    Liao W; Chen H; Yang Q; Lei X
    IEEE Trans Med Imaging; 2008 Oct; 27(10):1472-83. PubMed ID: 18815099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsupervised learning and mapping of active brain functional MRI signals based on hidden semi-Markov event sequence models.
    Faisan S; Thoraval L; Armspach JP; Metz-Lutz MN; Heitz F
    IEEE Trans Med Imaging; 2005 Feb; 24(2):263-76. PubMed ID: 15707252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting groups of coherent voxels in functional MRI data using spectral analysis and replicator dynamics.
    Müller K; Neumann J; Grigutsch M; von Cramon DY; Lohmann G
    J Magn Reson Imaging; 2007 Dec; 26(6):1642-50. PubMed ID: 17968963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of event-related fMRI data using best clustering bases.
    Meyer FG; Chinrungrueng J
    Inf Process Med Imaging; 2003 Jul; 18():623-34. PubMed ID: 15344493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive performance in mid-stage Parkinson's disease: functional connectivity under chronic antiparkinson treatment.
    Vancea R; Simonyan K; Petracca M; Brys M; Di Rocco A; Ghilardi MF; Inglese M
    Brain Imaging Behav; 2019 Feb; 13(1):200-209. PubMed ID: 28942477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa versus non-levodopa brain language fMRI in Parkinson's disease.
    Arantes PR; Gobato HH; Davoglio BB; Barreiros MÂ; Felício AC; Barsottini OG; Andrade LA; Amaro Junior E
    Einstein (Sao Paulo); 2012; 10(2):171-9. PubMed ID: 23052452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local linear discriminant analysis (LLDA) for group and region of interest (ROI)-based fMRI analysis.
    McKeown MJ; Li J; Huang X; Lewis MM; Rhee S; Young Truong KN; Wang ZJ
    Neuroimage; 2007 Sep; 37(3):855-65. PubMed ID: 17627850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain dopaminergic modulation associated with executive function in Parkinson's disease.
    Farid K; Sibon I; Guehl D; Cuny E; Burbaud P; Allard M
    Mov Disord; 2009 Oct; 24(13):1962-9. PubMed ID: 19672989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.